UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000019292
Receipt No. R000022288
Scientific Title The clinical research of the relationship between glycemic control evaluation and oxidative stress and vascular endothelial dysfunction in the diabetes patient, with Evaluation of a new measure of blood glucose variability ,"ADRR"
Date of disclosure of the study information 2015/10/09
Last modified on 2019/07/26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The clinical research of the relationship between glycemic control evaluation and oxidative stress and vascular endothelial dysfunction in the diabetes patient, with Evaluation of a new measure of blood glucose variability ,"ADRR"
Acronym ADRR (Average daily risk range) and oxidative stress/vascular endothelial dysfunction
Scientific Title The clinical research of the relationship between glycemic control evaluation and oxidative stress and vascular endothelial dysfunction in the diabetes patient, with Evaluation of a new measure of blood glucose variability ,"ADRR"
Scientific Title:Acronym ADRR (Average daily risk range) and oxidative stress/vascular endothelial dysfunction
Region
Japan

Condition
Condition Patients on insulin therapy
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to clarify and blood sugar fluctuations evaluation using ADRR in diabetic patients on insulin therapy, oxidative stress is an important factor in cardiovascular disease onset, the relevance of the vascular endothelial dysfunction and atherosclerosis.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes ADRR(Average daily risk range)
Oxidative stress marker (serum 3-nitro-tyrosine, urinary 8-OHdG / Cr, urinary 8-iso-PGF2 alpha / Cr)
(After 4 months of start of the study)
Key secondary outcomes Blood sugar-related inspection: HbA1c, glycated albumin, blood glucose level, 1.5-AG
FMD:Flow Mediated Dilation
High sensitivity CRP
Urinary albumin / creatinine ratio

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Device,equipment
Interventions/Control_1 Johnson & Johnson
Blood glucose meter
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >=
Gender Male and Female
Key inclusion criteria (1)Patient who is doing a self monitoring of blood glucose and a self-insulin injection.
(2) Patient who is doing the insulin injection from before more than 6 months at the registration.
(3)Individual who has the ability of consent and can sign a written informed consent
Key exclusion criteria (1)Individual who has a smoking habit.
(2)Patient with depression, alcohol-dependent patient.
(3)Cancer patient
(4)Patient who has taken a medication which affects to blood glucose levels, such as steroid, anti-cancer agent and interferon.
(5)Woman who is pregnant, or possibility of pregnant, or wishes to pregnant, or lactating
(6)Individual who is considered unsuitable for inclusion by the attending physician.
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Daisuke
Middle name
Last name Koya
Organization Kanazawa Medical University
Division name Daibetology & Endocrinology
Zip code 920-0293
Address 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa, 920-0293
TEL 076-286-2211
Email koya0516@kanazawa-med.ac.jp

Public contact
Name of contact person
1st name Yuka
Middle name
Last name Kuroshima
Organization Kanazawa Medical University
Division name Daibetology & Endocrinology
Zip code 920-0293
Address 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa, 920-0293
TEL 076-286-2211
Homepage URL
Email naipicrc@kanazawa-med.ac.jp

Sponsor
Institute Kanazawa Medical University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kanazawa Medical University Hospital Clinical trials study center
Address 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa
Tel 076-286-3511
Email tiken@kanazawa-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 金沢医科大学病院/Kanazawa Medical University Hospital.

Other administrative information
Date of disclosure of the study information
2015 Year 10 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2015 Year 09 Month 24 Day
Date of IRB
2015 Year 09 Month 28 Day
Anticipated trial start date
2015 Year 10 Month 01 Day
Last follow-up date
2020 Year 07 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 10 Month 09 Day
Last modified on
2019 Year 07 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022288

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.